Abstract
Drawing on previous research, this study aimed to assess the impact of COVID-19 vaccines on the Delta variant within the context of the Maldives. Using a retrospective design, the study analyzed comprehensive COVID-19 case data from multiple sources, including the Health Protection Agency (HPA), covering the initial reported cases until the end of December 2021. Notably, the data revealed a surge in Delta variant cases three months after administering the first vaccine dose to more than two-thirds of the population, suggesting a single dose was insufficient against Delta variant. However, following the administration of the second dose and additional restrictions, a gradual decline in COVID-19 cases was observed. These findings underscore the importance of implementing the World Health Organization (WHO)-recommended preventive measures in conjunction with vaccination, particularly when cases begin to rise, as supported by studies from other countries.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
